Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
Elan Corp PLC (NYSE:ELN)7/28/2010
most recent headlinesmore headlines:       
THURSDAY, JULY 22, 2010
2:00 AMElan Reports Second Quarter and First Half 2010 Financial Results - BusinessWire
THURSDAY, JULY 15, 2010
5:30 PMElan Corporation, plc Reaches Agreement in Principle for Settlement of Investigation of Past Zonegran Sales and Marketing Activities - BusinessWire
THURSDAY, JULY 08, 2010
4:30 PMElan Announces Webcast of Second Quarter 2010 Financial Results - BusinessWire
TUESDAY, JULY 06, 2010
6:47 AMElan Corporation plc names Eliseo O. Salinas, MD, MSc as executive vice president and chief medical officer - M2
2:00 AMEliseo O. Salinas, MD, MSc Joins Elan as Executive Vice President and Chief Medical Officer - BusinessWire
TUESDAY, JUNE 08, 2010
4:30 PMElan to Present at the Goldman Sachs 31st Annual Healthcare Conference - BusinessWire
THURSDAY, JUNE 03, 2010
2:00 AMElan Corporation, plc Board Announces CEO Agreement - BusinessWire
TUESDAY, JUNE 01, 2010
4:52 PMElan to Present at the Jefferies Global Life Sciences Conference - BusinessWire
TUESDAY, MAY 25, 2010
8:17 AMOceana Therapeutics Announces David S. Tierney, MD, Featured in the Inaugural Irish Life Science 50; Honor Presented by the President of Ireland - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.